StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Acadia Pharma (ACAD) to Resume Trading at 4:35 p.m., Study Did Not Meet Primary Endpoint
March 11, 2024 4:10 PM
Acadia Pharma (NASDAQ: ACAD) to Resume Trading at 4:35 p.m., Study Did Not Meet Primary Endpoint Acadia Pharmaceuticals Inc. (Nasdaq ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trading Halts
Next Articles
Acadia Pharmaceuticals (ACAD) Stock Selloff Is Over Done Says UBS, 'the level of sell-off is surprising to us'
March 12, 2024 4:07 PM
Mizuho Downgrades Acadia Pharmaceuticals (ACAD) to Neutral
March 12, 2024 4:51 AM
Form 8-K ACADIA PHARMACEUTICALS For: Mar 11
March 11, 2024 4:06 PM
Acadia Pharma (ACAD) Reports Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin
March 11, 2024 4:05 PM
Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia
March 11, 2024 4:05 PM
Acadia Pharma (ACAD) Halted, News Pending
March 11, 2024 4:01 PM
